Literature DB >> 34463553

CT Findings of COVID-19-associated Pulmonary Mucormycosis: A Case Series and Literature Review.

Mandeep Garg1, Nidhi Prabhakar1, Valliappan Muthu1, Shameema Farookh1, Harsimran Kaur1, Vikas Suri1, Ritesh Agarwal1.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34463553      PMCID: PMC8717687          DOI: 10.1148/radiol.2021211583

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  42 in total

1.  Rhinocerebral mucormycosis in COVID-19 patient with diabetes a deadly trio: Case series from the north-western part of India.

Authors:  Hardeva Ram Nehara; Inder Puri; Vipin Singhal; Sunil Ih; Bhagirath Ram Bishnoi; Pramendra Sirohi
Journal:  Indian J Med Microbiol       Date:  2021-05-26       Impact factor: 0.985

2.  Maxillofacial Infections in Covid-19 Era-Actuality or the Unforeseen: 2 Case Reports.

Authors:  D Sai Krishna; Harsha Raj; Pranav Kurup; Mehak Juneja
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-05-17

3.  Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).

Authors:  Mahboobeh Karimi-Galougahi; Shima Arastou; Sara Haseli
Journal:  Int Forum Allergy Rhinol       Date:  2021-03-13       Impact factor: 3.858

4.  Secondary infection with rhino-orbital cerebral mucormycosis associated with COVID-19.

Authors:  Liane O Dallalzadeh; Daniel J Ozzello; Catherine Y Liu; Don O Kikkawa; Bobby S Korn
Journal:  Orbit       Date:  2021-03-23

5.  COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.

Authors:  Ricardo Rabagliati; Nicolás Rodríguez; Carolina Núñez; Alvaro Huete; Sebastian Bravo; Patricia Garcia
Journal:  Emerg Infect Dis       Date:  2021-03-24       Impact factor: 6.883

6.  Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum.

Authors:  S Sharma; M Grover; S Bhargava; S Samdani; T Kataria
Journal:  J Laryngol Otol       Date:  2021-04-08       Impact factor: 1.469

7.  Pulmonary aspergillosis and mucormycosis in a patient with COVID-19.

Authors:  Andre K Johnson; Zeron Ghazarian; Kristina D Cendrowski; Jon G Persichino
Journal:  Med Mycol Case Rep       Date:  2021-04-07

8.  Autopsy Proven Pulmonary Mucormycosis Due to Rhizopus microsporus in a Critically Ill COVID-19 Patient with Underlying Hematological Malignancy.

Authors:  Christoph Zurl; Martin Hoenigl; Eduard Schulz; Stefan Hatzl; Gregor Gorkiewicz; Robert Krause; Philipp Eller; Juergen Prattes
Journal:  J Fungi (Basel)       Date:  2021-01-27

9.  ECMM/ISHAM recommendations for clinical management of COVID -19 associated mucormycosis in low- and middle-income countries.

Authors:  Shivaprakash M Rudramurthy; Martin Hoenigl; Jacques F Meis; Oliver A Cornely; Valliappan Muthu; Jean Pierre Gangneux; John Perfect; Arunaloke Chakrabarti
Journal:  Mycoses       Date:  2021-06-16       Impact factor: 4.377

View more
  14 in total

1.  Histopathologically Confirmed Pulmonary Mucormycosis as a Complication of COVID-19: a Case Report from Romania and Insight into Pathology.

Authors:  George Sebastian Gherlan; Maria Cristina Hoara; Sebastian George Smadu; Corneliu Petru Popescu; Petronela Ionescu; Simin-Aysel Florescu
Journal:  Maedica (Bucur)       Date:  2022-03

2.  COVID-19-Associated Pulmonary Mucormycosis: An Underdiagnosed Entity with High Mortality.

Authors:  Valliappan Muthu; Ritesh Agarwal; Arunaloke Chakrabarti
Journal:  Mycopathologia       Date:  2022-06-12       Impact factor: 3.785

3.  Serum iron indices in COVID-19-associated mucormycosis: A case-control study.

Authors:  Mohan Kumar H; Prashant Sharma; Shivaprakash M Rudramurthy; Inderpaul Singh Sehgal; Kuruswamy Thurai Prasad; Ashok Kumar Pannu; Reena Das; Naresh K Panda; Navneet Sharma; Arunaloke Chakrabarti; Ritesh Agarwal; Valliappan Muthu
Journal:  Mycoses       Date:  2021-11-16       Impact factor: 4.931

4.  Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap.

Authors:  Cornelia Geisler Crone; Jannik Helweg-Larsen; Morten Steensen; Maiken Cavling Arendrup; Marie Helleberg
Journal:  J Mycol Med       Date:  2021-11-18       Impact factor: 2.391

5.  Pulmonary Artery Pseudoaneurysm in COVID-19-Associated Pulmonary Mucormycosis: Case Series and Systematic Review of the Literature.

Authors:  Himanshu Pruthi; Valliappan Muthu; Harish Bhujade; Arun Sharma; Abhiman Baloji; Rao G Ratnakara; Amanjit Bal; Harkant Singh; Manavjit Singh Sandhu; Sunder Negi; Arunaloke Chakrabarti; Manphool Singhal
Journal:  Mycopathologia       Date:  2021-12-22       Impact factor: 2.574

Review 6.  COVID-19 associated mucormycosis: evolving technologies for early and rapid diagnosis.

Authors:  Rachel Samson; Mahesh Dharne
Journal:  3 Biotech       Date:  2021-12-06       Impact factor: 2.893

7.  COVID-19 associated with pulmonary mucormycosis; a case series.

Authors:  Okba F Ahmed; Saoud Al-Neaimy; Fahmi H Kakamad; Razhan K Ali; Tomas M Mikael; Ahmed Gh Hamasaeed; Shvan H Mohammed; Rawezh Q Salih; Abdulwahid M Salh; Muhammed Gh Hamasaeed
Journal:  Ann Med Surg (Lond)       Date:  2022-03-03

8.  The Integral Role of Radiology in the Diagnosis and Management of COVID-19-Associated Mucormycosis Infections.

Authors:  Anuj Prabhakar; Nidhi Prabhakar; Mandeep Garg; Ajay Kumar
Journal:  Am J Trop Med Hyg       Date:  2022-02-09       Impact factor: 2.345

Review 9.  Definition, diagnosis, and management of COVID-19-associated pulmonary mucormycosis: Delphi consensus statement from the Fungal Infection Study Forum and Academy of Pulmonary Sciences, India.

Authors:  Valliappan Muthu; Ritesh Agarwal; Atul Patel; Soundappan Kathirvel; Ooriapadickal Cherian Abraham; Ashutosh Nath Aggarwal; Amanjit Bal; Ashu Seith Bhalla; Prashant N Chhajed; Dhruva Chaudhry; Mandeep Garg; Randeep Guleria; Ram Gopal Krishnan; Arvind Kumar; Uma Maheshwari; Ravindra Mehta; Anant Mohan; Alok Nath; Dharmesh Patel; Shivaprakash Mandya Rudramurthy; Puneet Saxena; Nandini Sethuraman; Tanu Singhal; Rajeev Soman; Balamugesh Thangakunam; George M Varghese; Arunaloke Chakrabarti
Journal:  Lancet Infect Dis       Date:  2022-04-04       Impact factor: 71.421

Review 10.  Invasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients.

Authors:  Francesca Raffaelli; Eloisa Sofia Tanzarella; Gennaro De Pascale; Mario Tumbarello
Journal:  J Fungi (Basel)       Date:  2022-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.